| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 0.001 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.002 |